Jefferies Starts Allscripts-Misys Healthcare (MDRX) at Buy

Jefferies initiates coverage on Allscripts-Misys Healthcare (NASDAQ: MDRX) with a Buy. PT $25.00.

The firm notes:

• Revenue growth remains above 10%, driven by new wins and cross-selling
  
• Gross margin improves as upgrade activity slows and resources shift back to new sale
  
• Sales leverage pushes SG&A down as % of revenue; R&D remains fairly flat

For an analyst ratings summary and ratings history on Allscripts-Misys Healthcare click here. For more ratings news on Allscripts-Misys Healthcare click here.

Shares of Allscripts-Misys Healthcare closed at $18.12 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
• Morgan Stanley Starts Target Hospitality (TH) at Overweight
• Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform